Time to Desaturation Less Than One Minute Predicts the Need for Long-Term Home Oxygen Therapy

References

1. 1.↵
   1. Celli BR,
   2. MacNee W

   ; ATS/ERS Task Force. Standards of the diagnosis and treatment of COPD. Eur Respir J 2004;23(6):932–946. Erratum in: Eur Respir J 2006;27(1):242.

   OpenUrlFREE Full Text
2. 2.↵
   1. Pauwels RA,
   2. Buist AS,
   3. Calverly PM,
   4. Jenkins CR,
   5. Hurd SS

   . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Workshop summary. Am J Respir Crit Care Med 2001;163(5):1256–1276.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Cranston JM,
   2. Crockett AJ,
   3. Moss JR,
   4. Alpers JH

   . Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;19(4):CD001744.

   OpenUrl
4. 4.↵
   1. Sciurba F,
   2. Criner GJ,
   3. Lee SM,
   4. Mohsenifar Z,
   5. Shade D,
   6. Silvka W,
   7. Wise RA,
   8. NETT Research Group,
   9. et al

   . Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 2003;167(11):1522–1527.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111–117.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.
   1. -Redelmeier DA,
   2. Bayoumi AM,
   3. Goldstein RS,
   4. Guyatt GH

   . Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crir Care Med 1997;155(4):1278–1282.

   OpenUrl
7. 7.↵
   1. Nici L

   . The mayor limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscle vs.lower limb muscle dysfunction vs. dynamic hyperinflation. J Appl Physiol 2008;105(2):760–761.

   OpenUrlPubMed
8. 8.↵
   1. Garcia-Talavera I,
   2. Hernández C,
   3. Macario C,
   4. De Torres JP,
   5. Celli BR,
   6. Aguirre-Jaime A

   . Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO₂ between 60 and 70 mmHg. Respir Med 2008;102(7):1026–1032.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Gosselink R,
   2. Troosters T,
   3. Decramer M

   . Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153(3):976–980.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Troosters T,
    2. Vilaro J,
    3. Rabinovich R,
    4. Casas A,
    5. Baebera JA,
    6. Rodrigurz-Roisin R,
    7. Roca J

    . Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J 2002;20(3):564–569.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Takigawa N,
    2. Tada A,
    3. Soda Ryo,
    4. Date H,
    5. Yamashita M,
    6. Endo S,
    7. et al

    . Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med 2007;101(3):561–567.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Casanova C,
    2. Cote C,
    3. Marín JM,
    4. Pinto-Plata V,
    5. De Torres JP,
    6. Aguirre-Jaime A,
    7. Celli BR

    . Distance and oxygen desaturation Turing the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008;134(4):746–752.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93(3):391–398.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1(8222):681–686.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Gorecka D,
    2. Gorzelak K,
    3. Sliwinski P,
    4. Tobiasz M,
    5. Zielinski J

    . Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997;52(8):674–679.

    OpenUrlAbstract
16. 16.↵
    1. Nonoyama ML,
    2. Brooks D,
    3. Guyatt GH,
    4. Goldstein RS

    . Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007;176(4):343–346.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. McDonald CF,
    2. Blyth CM,
    3. Lazarus MD,
    4. Marschner I,
    5. Barter CE

    . Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med 1995;152(5 Pt 1):1616–1619.

    OpenUrlPubMedWeb of Science
18. 18.↵
    1. Eaton T,
    2. Garret JE,
    3. Young P,
    4. Fergusson W,
    5. Kolbe J,
    6. Rudkin S,
    7. Whyte K

    . Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 2002;20(2):306–312.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Fujimoto K,
    2. Matsuzawa Y,
    3. Yamaguchi S,
    4. Koizumi T,
    5. Kubo K

    . Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia. Chest 2002;122(2):457–463.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Jolly EC,
    2. Di Boscio V,
    3. Aguirre L,
    4. Luna CM,
    5. Berensztein S,
    6. Gene RJ

    . Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia. Chest 2001;120(2):437–443.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Pinto-Plata VM,
    2. Cote C,
    3. Cabral H,
    4. Taylor J,
    5. Celli BR

    . The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004;23(1):28–33.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Paciocco G,
    2. Martinez FJ,
    3. Bossone E,
    4. Pielsticker E,
    5. Gillespie B,
    6. Rubenfire M

    . Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001;17(4):647–652.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Lettieri CJ,
    2. Nathan SD,
    3. Browning RF,
    4. Barnett SD,
    5. Ahmad S,
    6. Shorr AF

    . The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med 2006;100(10):1734–1741.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Poulain M,
    2. Durand F,
    3. Palomba B,
    4. Ceugniet F,
    5. Desplan J,
    6. Varray A,
    7. Préfaut C

    . 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest 2003;123(5):1401–1407.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Morante F,
    2. Guell R,
    3. Mayos M

    . [Efficacy of the 6-minute walk test in evaluating ambulatory oxygen therapy]. Arch Bronconeumol 2005;41(11):596–600. Article in Spanish.

    OpenUrlPubMed
26. 26.↵
    1. Drummond MB,
    2. Blackford AL,
    3. Benditt JO,
    4. Make BJ,
    5. Sciurba FC,
    6. McCormack MC,
    7. et al

    . Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients. Retrospective analysis of the National Emphysema Treatment Trial. Chest 2008;134(3):497–506.

    OpenUrlCrossRefPubMedWeb of Science